HBAN:SIXHelvetia Baloise Holding AG Analysis
Data as of 2026-05-18 - not real-time
$15.41
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Huntington Bancshares is trading at $15.41, roughly 20% below its 52‑week high and well under the DCF‑derived fair value of $29.25, suggesting a sizable upside. Valuation metrics such as a trailing P/E of 11.9 versus the industry average of 16.5 and a price‑to‑book of 1.05 underscore the stock’s relative cheapness. Fundamentally, the bank delivered a 33.6% revenue surge year‑over‑year and posted a forward EPS of $1.90, driving the forward P/E down to 8.1, which points to strong earnings momentum. The dividend yield of 4.0% with a payout ratio under 50% indicates a sustainable income stream.
On the technical side, the 20‑day SMA sits just above the 50‑day SMA, while the RSI of 36 hints at mild oversold conditions, yet the MACD remains bearish and price is confined between a $15.17 support and $17.35 resistance. Volume is trending higher and the Fear & Greed Index reads “Extreme Greed,” reflecting bullish market sentiment that could accelerate price appreciation. Recent upgrades from analysts, including a raised price target to $18, reinforce the upside narrative, though the bearish MACD and proximity to support advise caution in the near term.
On the technical side, the 20‑day SMA sits just above the 50‑day SMA, while the RSI of 36 hints at mild oversold conditions, yet the MACD remains bearish and price is confined between a $15.17 support and $17.35 resistance. Volume is trending higher and the Fear & Greed Index reads “Extreme Greed,” reflecting bullish market sentiment that could accelerate price appreciation. Recent upgrades from analysts, including a raised price target to $18, reinforce the upside narrative, though the bearish MACD and proximity to support advise caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support
- Bearish MACD signal
- Increasing volume suggests potential bounce
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to peers
- Strong revenue and EPS growth
- Robust dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value implies ~28% upside
- Consistent earnings expansion and credit performance
- Stable dividend and low debt‑to‑equity profile
Key Metrics & Analysis
Financial Health
Revenue Growth33.60%
Profit Margin26.60%
P/E Ratio11.9
ROE8.39%
ROA0.90%
P/B Ratio1.1
Op. Cash Flow$2.5B
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI36.9
Support$15.17
Resistance$17.35
MA 20$16.32
MA 50$16.02
MA 200$16.76
MACDBearish
VolumeIncreasing
Fear & Greed Index87.54
Valuation
Fair Value$29.25
Target Price$19.73
Upside/Downside28.06%
GradeUndervalued
TypeBlend
Dividend Yield4.02%
Risk Assessment
Beta1.04
Volatility24.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.